Check out the announcement today and how CHEAP this stock is at the moment!Possible counter offer coming as well as mentioned by someone else previously.It's definately a BUY at the moment imho.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%